抗抑郁药和脂肪含量的变化

Y. W. Francis Lam Pharm.D., FCCP
{"title":"抗抑郁药和脂肪含量的变化","authors":"Y. W. Francis Lam Pharm.D., FCCP","doi":"10.1002/pu.31225","DOIUrl":null,"url":null,"abstract":"<p>It is not uncommon for patients with depression to have obesity as a comorbid condition (Mulugeta et al., 2019). Although antidepressants have been implicated in weight gain in patients with depression, the research evidence is conflicting and little data exist for assessing weight changes after more than 12 months of antidepressant therapy.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 11","pages":"2"},"PeriodicalIF":0.0000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antidepressants and changes in adiposity\",\"authors\":\"Y. W. Francis Lam Pharm.D., FCCP\",\"doi\":\"10.1002/pu.31225\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>It is not uncommon for patients with depression to have obesity as a comorbid condition (Mulugeta et al., 2019). Although antidepressants have been implicated in weight gain in patients with depression, the research evidence is conflicting and little data exist for assessing weight changes after more than 12 months of antidepressant therapy.</p>\",\"PeriodicalId\":22275,\"journal\":{\"name\":\"The Brown University Psychopharmacology Update\",\"volume\":\"35 11\",\"pages\":\"2\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Brown University Psychopharmacology Update\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/pu.31225\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31225","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

抑郁症患者合并肥胖症的情况并不少见(Mulugeta 等人,2019 年)。虽然抗抑郁药被认为会导致抑郁症患者体重增加,但研究证据相互矛盾,而且几乎没有数据可用于评估抗抑郁药治疗超过 12 个月后的体重变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Antidepressants and changes in adiposity

It is not uncommon for patients with depression to have obesity as a comorbid condition (Mulugeta et al., 2019). Although antidepressants have been implicated in weight gain in patients with depression, the research evidence is conflicting and little data exist for assessing weight changes after more than 12 months of antidepressant therapy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Trial finds fezolinetant efficacious for vasomotor symptoms in menopause Study finds zuranolone impairs simulated driving performance Your Medication Information Weight-loss drugs improve outcomes in patients with alcohol use disorder Meta-analysis finds viloxazine effective for youths with ADHD
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1